Our website uses cookies to improve your user experience. If you continue browsing, we assume that you consent to our use of cookies. More information can be found in our Cookies Policy and Privacy Policy .
The new branding, from Wolff Olins, hopes to reflect the healthcare company’s biopharma ambitions following a demerger earlier this year.
Pharmaceutical company GSK has revealed a rebrand, as it refocuses its efforts in the area of “biopharma innovation”.
London-based consultancy Wolff Olins is behind the new look, which includes an updated logo, bespoke typeface, and motion assets.
The rebrand follows GSK’s announcement earlier this year that its consumer-facing products – which include Sensodyne and Panadol – will be housed under a separate brand entitled Haleon. In May, the British pharmaceutical company also changed its name from GlaxoSmithKline to simply GSK.
“GSK is moving towards our most significant corporate change in 20 years with the demerger of our Consumer Healthcare business, Haleon,” says GSK CEO Emma Walmsley. “GSK will now be purely focused on biopharma innovation,” she adds, outlining ambitions for development in the health, science and technology sector.
In an attempt to meet GSK’s redefined goals, Wolff Olins looked to the imagery from the biosciences sector. Wolff Olins global executive creative director Emma Barratt explains that the hope was to embrace “extraordinary adaptability” in multiple forms – from the human immune system, to technological possibilities and GSK’s own staff.
This meant that the identity had to “retain a feeling of constant innovation” but also be balanced with a “need for warmth”, Barratt says. These include curved forms which “evoke the highly adaptable nature of the human immune system”; they can be seen on multiple touchpoints including staff apparel and printed materials.
While the new logo retains the previous branding’s orange hue, it is now housed in a new shape called the “signal”. The colours have also been inverted. The company’s name now appears in uppercase rather than lowercase in the logo.
According to the design team, accessibility was a significant focus for the rebrand, and assets have been tested for legibility across digital and print uses. Manchester-based type foundry Face37 worked on a bespoke typeface for the new identity, in line with these accessibility aims. A suite of motion graphics has also been crafted.
What do you think of GSK’s rebrand? Let us know in the comments below.

Lewis Moberly has created a typeface for the vegan band which targets neurodiverse consumers.
Nav Sawhney’s design aims to provide a low-cost, lightweight option for keeping up with domestic chores.
As inflation soars, we speak to designers about how current living conditions are affecting their work and practice.
This year many graduate shows are returning as hybrid events, offering digital and in-person showcases – here is our guide to what’s on offer.
Copyright © 2022 Centaur Media plc and / or its subsidiaries and licensors. All rights reserved.
built by interconnect/it
Xeim Limited, Registered in England and Wales with number 05243851
Registered office at Floor M, 10 York Road, London, SE1 7ND